Literature DB >> 33825077

Cerebrovascular Complications Associated with Marijuana Use.

Bayan Moustafa1, Fernando D Testai2.   

Abstract

PURPOSE OF REVIEW: In the last few years, the attitude toward marijuana in many parts of the world has shifted from illicit to legalized for medical use and to decriminalized. In parallel, there has been a gradual increase in the consumption of this product in the general population, particularly among adolescents and young adults. Marijuana is generally perceived as a harmless drug. However, data obtained in observational studies and preclinical models have established associations between cannabis use and cardiovascular events. In addition, there is emerging evidence linking marijuana use to cerebrovascular complications. Here we provide a critical review of the literature with special emphasis on the association of cannabinoids with stroke and the possible pathogenic mechanisms involved. RECENT
FINDINGS: Ischemic and hemorrhagic stroke have been described in association with cannabis use, particularly in young individuals. Cerebral infarction remains the most commonly reported stroke subtype seen in marijuana users. Several pathogenic mechanisms have been proposed to explain this association, including multifocal intracranial stenosis, reversible cerebral vasoconstriction syndrome, and coexisting vascular risk factors. Cannabis use is increasingly recognized in young individuals presenting with acute stroke. Our understanding of the pathogenic mechanisms associated with cannabis use and stroke is limited but rapidly evolving. Healthcare providers should educate patients about the potential cardiovascular and cerebrovascular complications related to marijuana or cannabinoids use.

Entities:  

Keywords:  Cannabinoids; Endocannabinoid system; Intracerebral hemorrhage; Ischemic stroke; RCVS; Δ-9-Tetrahydocannabinol

Year:  2021        PMID: 33825077     DOI: 10.1007/s11910-021-01113-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  47 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

2.  Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction.

Authors:  Roy A Wise
Journal:  Trends Neurosci       Date:  2009-09-14       Impact factor: 13.837

3.  A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae).

Authors:  Karl W Hillig; Paul G Mahlberg
Journal:  Am J Bot       Date:  2004-06       Impact factor: 3.844

Review 4.  Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Authors:  P Pacher; R Mechoulam
Journal:  Prog Lipid Res       Date:  2011-02-02       Impact factor: 16.195

Review 5.  Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.

Authors:  R G Pertwee
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

6.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

7.  Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.

Authors:  Orrin Devinsky; Anup D Patel; J Helen Cross; Vicente Villanueva; Elaine C Wirrell; Michael Privitera; Sam M Greenwood; Claire Roberts; Daniel Checketts; Kevan E VanLandingham; Sameer M Zuberi
Journal:  N Engl J Med       Date:  2018-05-17       Impact factor: 91.245

8.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

9.  Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

Authors:  Miriam Melis; Marco Pistis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Gian Luigi Gessa
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

Review 10.  Cannabinoids and the expanded endocannabinoid system in neurological disorders.

Authors:  Luigia Cristino; Tiziana Bisogno; Vincenzo Di Marzo
Journal:  Nat Rev Neurol       Date:  2019-12-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.